scholarly article | Q13442814 |
P356 | DOI | 10.1007/978-1-62703-523-1_10 |
P953 | full work available at URL | https://link.springer.com/content/pdf/10.1007/978-1-62703-523-1_10 |
P698 | PubMed publication ID | 23852601 |
P2093 | author name string | Olaf Groß | |
Christina J. Thomas | |||
Katharina S. Schneider | |||
P2860 | cites work | The inflammasomes | Q24304087 |
The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta | Q24305136 | ||
Active caspase-1 is a regulator of unconventional protein secretion | Q24308770 | ||
AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC | Q24319706 | ||
Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica | Q24649598 | ||
Gout-associated uric acid crystals activate the NALP3 inflammasome | Q28131797 | ||
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf | Q28266417 | ||
Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme | Q28287610 | ||
Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin | Q28586508 | ||
Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression | Q29615589 | ||
Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes | Q29615593 | ||
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors | Q29615665 | ||
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals | Q29615704 | ||
Immunological and inflammatory functions of the interleukin-1 family | Q29619669 | ||
Identification of calcium-activated neutral protease as a processing enzyme of human interleukin 1 alpha | Q33702165 | ||
Monogenic autoinflammatory diseases: new insights into clinical aspects and pathogenesis | Q34489840 | ||
Unconventional mechanisms of protein transport to the cell surface of eukaryotic cells | Q34790521 | ||
Inflammasome activation and IL-1β target IL-1α for secretion as opposed to surface expression | Q35518745 | ||
Unraveling the biological roles of reactive oxygen species | Q35653213 | ||
IL-3 in dendritic cell development and function: a comparison with GM-CSF and IL-4. | Q35916587 | ||
Demonstration and characterization of two distinct human leukocytic pyrogens | Q36273508 | ||
The IL-1 family: regulators of immunity | Q37676929 | ||
Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production | Q39774272 | ||
Tumoricidal alveolar macrophage and tumor infiltrating macrophage cell lines | Q41665612 | ||
Inflammasome activators induce interleukin-1α secretion via distinct pathways with differential requirement for the protease function of caspase-1. | Q53178008 | ||
Generation of Mouse Bone Marrow-Derived Macrophages | Q62382512 | ||
Processing proIL-1 beta decreases detection by a proIL-1 beta specific ELISA but increases detection by a conventional ELISA | Q72574797 | ||
Measuring the inflammasome | Q83289252 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | inflammasome complex | Q412405 |
P1104 | number of pages | 19 | |
P304 | page(s) | 117-135 | |
P577 | publication date | 2013-01-01 | |
P1433 | published in | Methods in Molecular Biology | Q15752859 |
P1476 | title | Inflammasome Activation and Inhibition in Primary Murine Bone Marrow-Derived Cells, and Assays for IL-1α, IL-1β, and Caspase-1 | |
P478 | volume | 1040 |
Q24810414 | Aberrant expression of interleukin-1β and inflammasome activation in human malignant gliomas |
Q47225640 | Advances in Proteomic Techniques for Cytokine Analysis: Focus on Melanoma Research |
Q40499822 | K+ Efflux-Independent NLRP3 Inflammasome Activation by Small Molecules Targeting Mitochondria |
Q60212390 | Pyroptosis Induction and Detection |
Q47104687 | Specific Surface Modifications of Silica Nanoparticles Diminish Inflammasome Activation and In Vivo Expression of Selected Inflammatory Genes. |
Q47251504 | The Inflammasome Drives GSDMD-Independent Secondary Pyroptosis and IL-1 Release in the Absence of Caspase-1 Protease Activity |
Search more.